| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4247867 | Radiologic Clinics of North America | 2007 | 9 Pages |
Abstract
One of the major strengths of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) in breast cancer imaging is in the evaluation of patients who have suspected loco-regional recurrence or distant metastasis. In general, FDG-PET is more sensitive than conventional imaging for the detection of recurrent disease. Because of its ability to more accurately stage patients who have advanced breast cancer, FDG-PET has a significant impact on choice of treatment and management in this patient group.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
William B. MD,